1. Ingram RH Jr. Asthma and airway hyperresponsiveness. Annu Rev Med. 1991;42:139-50. doi: 10.1146/annurev.me.42.020191.001035. PMID: 2035960.
2. Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuysen CI, et al. Genetic susceptibility to asthma--bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med. 1995;333(14):894-900.
3. Tillie-Leblond I, Montani D, Crestani B, De Blic J, Humbert M, Tunon-de-Lara M, et al. Relation between inflammation and symptoms in asthma. Allergy. 2009;64(3):354-67.
4. Johansson H, Mersha TB, Brandt EB, Khurana Hershey GK. Interactions between environmental pollutants and genetic susceptibility in asthma risk. Curr Opin Immunol. 2019;60(14):156-62.
5. Alizadeh-Navaei R, Rafiei A, Hedayatizadeh-Omran A, Mohammadzadeh I, Arabi M. Gene susceptibility in Iranian asthmatic patients: a narrative review. Ann Med Health Sci Res. 2014;4(6):837-40.
6. Dharmage SC, Perret JL, Custovic A. Epidemiology of Asthma in Children and Adults. Front Pediatr. 2019;7:246.
7. Fazlollahi MR, Najmi M, Fallahnezhad M, Sabetkish N, Kazemnejad A, Bidad K, et al. The prevalence of asthma in Iranian adults: The first national survey and the most recent updates. Clin Respir J. 2018;12(5):1872-81.
8. Weiss ST, Raby BA, Rogers A. Asthma genetics and genomics 2009. Curr Opin Genet Dev. 2009;19(3):279-82.
9. Lee YC, Cheon KT, Lee HB, Kim W, Rhee YK, Kim DS. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with asthma. Allergy. 2000;55(10):959-63.
10. Shao Z, Jin H, Sun H, Dong C, Xu B, Zhan L. Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to pediatric asthma: A meta-analysis. J Renin Angiotensin Aldosterone Syst. 2020;21(2):1470320320923475.
11. Kuba K, Imai Y, Penninger JM. Angiotensin-converting enzyme 2 in lung diseases. Curr Opinion Pharmacol. 2006;6(3):271-6.
12. Kaur P, Muthuraman A, Kaur M. The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives. ACS Chem Neurosci. 2015;6(4):508-21.
13. Karamyan VT. Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19? Physiol Rep. 2021;9(5):e14796.
14. Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med. 2010;2(7):247-57.
15. Verma K, Pant M, Paliwal S, Dwivedi J, Sharma S. An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update. Front Pharmacol. 2021;12(2175).
16. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, Duijn CMv, Witteman JCM. ACEPolymorphisms.Circ Res. 2006;98(9):1123-33.
17. Han SY, Kwon YJ, Jo SK, Shin JH, Cha DR, Cho WY, et al. ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients. Korean J Intern Med. 2000;15(1):13-8.
18. Dorudinia A, Shamaei M, Karimi S, Javadi A, Mohammadi Ziazi L, Pourabdollah M. Evaluation of in-house polymerase chain reaction assay sensitivity, can it be utilized in limited-resources settings? Med J Islam Repub Iran. 2014;28:126.
19. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343-6.
20. Xu G, Fan G, Sun Y, Yu L, Wu S, Niu W. Association of angiotensin-converting enzyme gene I/D polymorphism with chronic obstructive pulmonary disease: a meta-analysis. J Renin Angiotensin Aldosterone Syst. 2018;19(2):1470320318770546.
21. Ding QL, Sun SF, Cao C, Deng ZC. Association between angiotensin-converting enzyme I/D polymorphism and asthma risk: a meta-analysis involving 11,897 subjects. J Asthma. 2012;49(6):557-62.
22. Zhang YG, Li XB, Zhang J, Huang J, He C, Tian C, et al. The I/D polymorphism of angiotensin-converting enzyme gene and asthma risk: a meta-analysis. Allergy. 2011;66(2):197-205.
23. Chagani T, Paré PD, Zhu S, Weir TD, Bai TR, Behbehani NA, et al. Prevalence of tumor necrosis factor-alpha and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma. Am J Respir Crit Care Med. 1999;160(1):278-82.
24. El-Shafei MS, Farres MN, Shahin RY. Evaluation of angiotensin converting enzyme gene polymorphism and susceptibility to bronchial asthma among Egyptians. Allergol Immunopathol (Madr). 2012;40(5):275-80.
25. Eryüksel E, Ceyhan BB, Bircan R, Avşar M, Cirakoğlu B. Angiotensin converting enzyme gene polymorphism in Turkish asthmatic patients. J Asthma. 2009;46(4):335-8.
26. Tomita H, Sato S, Matsuda R, Ogisu N, Mori T, Niimi T, et al. Genetic polymorphism of the angiotensin-converting enzyme (ACE) in asthmatic patients. Resp Med. 1998;92(12):1305-10.
27. Urhan M, Degirmenci I, Harmanci E, Gunes HV, Metintas M, Basaran A. High frequency of DD polymorphism of the angiotensin-converting enzyme gene in Turkish asthmatic patients. Allergy Asthma Proc. 2004;25(4):243-7.
28. Nakahama H, Obata K, Nakajima T, Nakamura H, Kitada O, Sugita M, et al. Renin-angiotensin system component gene polymorphism in Japanese bronchial asthma patients. J Asthma. 1999;36(2):187-93.
29. Cortez M, Matos A, Ferreira J, Lopes L, Gil A, Bicho M. ACE polymorphism in asthmatic patients. Clin Trans Allergy. 2013;3(1):P14.
30. Gao J, Lin Y, Xiao Y, Xu K, Xu W, Zhu Y, et al. Polymorphism of angiotensin-converting enzyme gene and genetic susceptibility to asthma with familial aggregation. Chin Med Sci J. 2000;15(1):24-8.
31. Eleni S, Dimitrios K, Vaya P, Areti M, Norma V, Magdalini G. Angiotensin-I converting enzyme gene and I/D polymorphism distribution in the Greek population and a comparison with other European populations. J Genet. 2008;87(1):91-3.